Blood vessel problems, white matter damage, and movement loss in Alzheimer’s

Vascular contribution to white matter lesions and motor dysfunction in AD and ADRD

['FUNDING_OTHER'] · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · NIH-11212260

Researchers are looking at whether small blood vessel damage in the brain leads to white matter changes that cause movement and balance problems in people with Alzheimer’s disease.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorRUTGERS BIOMEDICAL AND HEALTH SCIENCES (nih funded)
Locations1 site (Newark, UNITED STATES)
Trial IDNIH-11212260 on ClinicalTrials.gov

What this research studies

This project studies how vascular damage and white matter lesions in the brain contribute to walking, balance, and other motor problems in Alzheimer’s and related dementias. The team uses Alzheimer’s and Familial Danish Dementia mouse models alongside detailed brain imaging, blood vessel and tissue analyses, and motor behavior tests to link vascular changes to movement decline. By focusing on the basal ganglia and other motor-relevant regions, researchers aim to map which vascular and white matter changes come before motor symptoms. The work is designed to point to biological targets that could be tested in future human studies to prevent or slow motor deterioration.

Who could benefit from this research

Good fit: People with Alzheimer’s disease or AD-related dementias, especially those noticing early gait, balance, or other motor changes, would be most relevant to follow this work or consider future related trials.

Not a fit: People without Alzheimer’s or whose movement problems are known to be caused by non-vascular conditions may be less likely to benefit from these findings.

Why it matters

Potential benefit: If successful, the project could reveal vascular causes of motor decline in Alzheimer’s and suggest targets for treatments to slow or prevent movement problems.

How similar studies have performed: Prior clinical and animal studies have linked white matter lesions and small-vessel disease to motor deficits, but this project uses new models and focused vascular analyses to clarify cause-effect relationships.

Where this research is happening

Newark, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.